The analysis of TFAP2B gene in LUSC subtype (Figure 5B) revealed that significantly lower expression level was observed at stage 4 of lung cancer vs. stage 1 (p = 0.0423), which may indicate inhibition of TFAP2B gene expression during tumor development. Here, TFAP2B is linked to lung carcinoma.